Details for New Drug Application (NDA): 022198

✉ Email this page to a colleague

NDA 022198 describes SANCUSO, which is a drug marketed by Cumberland and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the SANCUSO profile page.

The generic ingredient in SANCUSO is granisetron. There are twenty-six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the granisetron profile page.

Summary for 022198

Tradename:	SANCUSO
Applicant:	Cumberland
Ingredient:	granisetron
Patents:	1

Pharmacology for NDA: 022198

Mechanism of Action	Serotonin 3 Receptor Antagonists

Medical Subject Heading (MeSH) Categories for 022198

Antiemetics
Serotonin Antagonists

Suppliers and Packaging for NDA: 022198

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
SANCUSO	granisetron	FILM, EXTENDED RELEASE;TRANSDERMAL	022198	NDA	Cumberland Pharmaceuticals Inc.	66220-637	66220-637-31	168 h in 1 POUCH (66220-637-31)
SANCUSO	granisetron	FILM, EXTENDED RELEASE;TRANSDERMAL	022198	NDA	Cumberland Pharmaceuticals Inc.	66220-637	66220-637-72	168 h in 1 POUCH (66220-637-72)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	FILM, EXTENDED RELEASE;TRANSDERMAL			Strength	3.1MG/24HR
Approval Date:	Sep 12, 2008	TE:		RLD:	Yes
Patent:	7,608,282	Patent Expiration:	Jan 22, 2025	Product Flag?	Y	Substance Flag?		Delist Request?
Patented Use:	USE OF GRANISETRON TRANSDERMAL SYSTEM TO TREAT/PREVENT CHEMOTHERAPY INDUCED NAUSEA AND VOMITING

Expired US Patents for NDA 022198

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Cumberland	SANCUSO	granisetron	FILM, EXTENDED RELEASE;TRANSDERMAL	022198-001	Sep 12, 2008	7,608,282	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.